Stockscreener 앱 받기
8.30
0.00%
0.00
전일 마감가:
$8.30
열려 있는:
$8.19
하루 거래량:
24,172
Relative Volume:
0.02
시가총액:
$10.00M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+3.75%
1개월 성능:
-1.78%
6개월 성능:
-98.84%
1년 성능:
-99.85%
1일 변동 폭
$8.1663
$8.4964
1주일 범위
$7.79
$8.90
52주 변동 폭
$6.71
$17,908.00
Cero Therapeutics Holdings Inc Stock (CERO) Company Profile
명칭
Cero Therapeutics Holdings Inc
전화
650-407-2376
주소
201 HASKINS WAY, SOUTH SAN FRANCISCO
CERO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CERO
Cero Therapeutics Holdings Inc
|
8.30 | 10.61M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Cero Therapeutics Holdings Inc Stock (CERO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-23 | 업그레이드 | D. Boral Capital | Hold → Buy |
Cero Therapeutics Holdings Inc 주식(CERO)의 최신 뉴스
CERo Therapeutics announces 1-for-20 reverse stock split effective June 13 - MSN
Short Interest Drops in CERo Therapeutics Holdings Inc. After Rally2025 Market Overview & Accurate Trade Setup Notifications - metal.it
CERo Therapeutics Delays 10-Q Filing Amid Valuation Issues - TipRanks
Is CERo Therapeutics Holdings Inc. undervalued by DCF analysisJuly 2025 Chart Watch & Stock Market Timing Techniques - newsyoung.net
Will CERo Therapeutics Holdings Inc. benefit from macro trendsWeekly Trade Recap & Fast Entry Momentum Trade Alerts - Newser
Analyzing CERo Therapeutics Holdings Inc. with multi timeframe chartsJuly 2025 Institutional & High Accuracy Buy Signal Tips - Newser
Best data tools to analyze CERo Therapeutics Holdings Inc. stockJuly 2025 PreEarnings & Growth-Oriented Investment Plans - Newser
Risk adjusted return profile for CERo Therapeutics Holdings Inc. Equity Warrant analyzedTrade Exit Summary & Safe Entry Zone Identification - Newser
CERo Therapeutics Holdings Inc. Sees Relief Buying After Extended DropJuly 2025 Weekly Recap & Stepwise Trade Signal Guides - sundaytimes.kr
Chartists Watching For Breakout in CERo Therapeutics Holdings Inc.Weekly Stock Report & Verified Technical Trade Signals - beatles.ru
Top Risks to Consider Before Buying CERo Therapeutics Holdings Inc. Stock2025 Momentum Check & Smart Swing Trading Techniques - Newser
What makes CERo Therapeutics Holdings Inc. stock price move sharplyWeekly Gains Report & Daily Oversold Bounce Ideas - Newser
What Technical Tools Say About CERo Therapeutics Holdings Inc. Recovery - 선데이타임즈
How high can CERo Therapeutics Holdings Inc. Equity Warrant stock goMarket Movers & Consistent Growth Equity Picks - Newser
What moving averages say about CERo Therapeutics Holdings Inc. [CPI Data]Stepwise Trade Execution Plans - Newser
What’s the RSI of CERo Therapeutics Holdings Inc. stockFree Top 5 Picks of the Week - classian.co.kr
CERo Therapeutics CERO 2025Q2 Earnings Preview Downside Risk Amid Regulatory Challenges - AInvest
CERo Therapeutics WRT CEROW 2025Q2 Earnings Preview Upside Potential on Strategic Partnerships - AInvest
CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Short Interest Up 94.5% in July - Defense World
WINT 8-K: Audit Chair Resigns, New Independent Director Appointed | WINT SEC FilingForm 8-K - Stock Titan
CERo Therapeutics Holdings, Inc. Announces Reverse Stock Split - ADVFN Brasil
Does CERo Therapeutics Holdings Inc. Equity Warrant show high probability of reboundPrice Action Trading with Volume Confirmation - Newser
CERo Therapeutics: D. Boral Capital Raises PT to $30 from $30 - AInvest
What is the risk reward ratio of investing in CERo Therapeutics Holdings Inc. Equity Warrant stock - Jammu Links News
What are the technical indicators suggesting about CERo Therapeutics Holdings Inc. Equity WarrantGet daily updates on promising stocks - Jammu Links News
Does CERo Therapeutics Holdings Inc. Equity Warrant stock perform well during market downturnsRapid capital growth - Jammu Links News
How volatile is CERo Therapeutics Holdings Inc. Equity Warrant stock compared to the marketMassive stock growth - Jammu Links News
How does CERo Therapeutics Holdings Inc. compare to its industry peersExceptional gains - Jammu Links News
Is CERo Therapeutics Holdings Inc. stock overvalued or undervaluedHigh-octane gains - Jammu Links News
Does CERo Therapeutics Holdings Inc. stock perform well during market downturnsBuild wealth faster with expert stock selection - Jammu Links News
What makes CERo Therapeutics Holdings Inc. Equity Warrant stock price move sharplyRapid growth trajectories - Jammu Links News
What is CERo Therapeutics Holdings Inc. company’s growth strategyBreakthrough stock performance - Jammu Links News
What are the latest earnings results for CERo Therapeutics Holdings Inc. Equity WarrantBuild a diversified portfolio for steady growth - Jammu Links News
How does CERo Therapeutics Holdings Inc. Equity Warrant compare to its industry peersBuild wealth faster with disciplined trading - Jammu Links News
Is CERo Therapeutics Holdings Inc. Equity Warrant a good long term investment - Jammu Links News
Should I hold or sell CERo Therapeutics Holdings Inc. Equity Warrant stock in 2025Stay ahead with daily expert stock picks - Jammu Links News
Why is CERo Therapeutics Holdings Inc. stock attracting strong analyst attentionUnlock powerful market insights for success - Jammu Links News
Fibonacci Support Holding Strong in CERo Therapeutics Holdings Inc.Low Risk Buy Zone Opportunity Watch Ongoing - beatles.ru
What are the latest earnings results for CERo Therapeutics Holdings Inc.Spectacular growth rates - Jammu Links News
CERo Therapeutics Holdings Inc. Stock Analysis and ForecastExceptional market performance - Jammu Links News
How does CERo Therapeutics Holdings Inc. Equity Warrant generate profit in a changing economyFree Stock Index Interpretation - Jammu Links News
Is CERo Therapeutics Holdings Inc. Equity Warrant a growth stock or a value stockFree Stock Trend Scanner For 2025 - Jammu Links News
What institutional investors are buying CERo Therapeutics Holdings Inc. stockBest Dividend Updates For Beginners - Jammu Links News
Resistance Break Could Fuel CERo Therapeutics Holdings Inc. RallyReal Time Trade Opportunity Alerts Monitor Market Surges - beatles.ru
CERo doses second patient in Phase 1 AML trial, reports expansion data - Investing.com Australia
CERo Therapeutics Doses Second Acute Myeloid Leukemia Patient with CER-1236 - GlobeNewswire
Can Traders Expect Breakout From CERo Therapeutics Holdings Inc. This WeekOptimized Watchlist With Daily Adjustments Launched - beatles.ru
Can CERo Therapeutics Holdings Inc. Equity Warrant rally from current levelsAI Screening for Swing Trade Picks Finds Momentum - metal.it
Why CERo Therapeutics Holdings Inc. Equity Warrant stock attracts strong analyst attentionShort Term Risk Analysis Forecast - beatles.ru
Recovery Signals Appearing in CERo Therapeutics Holdings Inc. ChartsEntry Points For Growing Stocks Identified by Models - metal.it
How CERo Therapeutics Holdings Inc. stock performs during market volatilityWeekly Hot Picks With Buy Confidence Released - metal.it
Cero Therapeutics Holdings Inc (CERO) 재무 분석
Cero Therapeutics Holdings Inc (CERO)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Cero Therapeutics Holdings Inc 주식 (CERO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| YK Bioventures Opportunities G | 10% Owner |
Dec 13 '24 |
Sale |
0.06 |
2,998,908 |
179,934 |
13,005,169 |
| YK Bioventures Opportunities G | 10% Owner |
Dec 12 '24 |
Sale |
0.07 |
1,614,541 |
113,018 |
16,004,077 |
| YK Bioventures Opportunities G | 10% Owner |
Dec 11 '24 |
Sale |
0.08 |
1,343,801 |
107,504 |
17,618,618 |
| YK Bioventures Opportunities G | 10% Owner |
Dec 06 '24 |
Sale |
0.12 |
1,236,874 |
148,425 |
21,383,909 |
| YK Bioventures Opportunities G | 10% Owner |
Dec 10 '24 |
Sale |
0.09 |
1,570,947 |
141,385 |
18,962,419 |
| YK Bioventures Opportunities G | 10% Owner |
Dec 09 '24 |
Sale |
0.11 |
850,543 |
93,560 |
20,533,366 |
| SLOAN STUART M | 10% Owner |
Sep 25 '24 |
Sale |
0.10 |
532,486 |
55,538 |
21,067,956 |
| YK Bioventures Opportunities G | 10% Owner |
Oct 10 '24 |
Sale |
0.10 |
3,250,000 |
325,000 |
22,620,783 |
0.94%
1.72%
자본화:
|
볼륨(24시간):